Close

Leerink Partners Reinitiates Amgen (AMGN) at Market Perform

February 4, 2016 4:55 PM EST Send to a Friend
Leerink Partners reinitiates coverage on Amgen (NASDAQ: AMGN) with a Market Perform rating and a price target of $179.00.Analyst Geoffrey ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login